OncoSec Medical, Inc. (NASDAQ:ONCS)

About the company

OncoSec Medical, Inc. is a biotechnology company, which engages in designing, developing, and commercializing therapies for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor. The company was founded by Avtar S. Dhillon and Punit S. Dhillon on February 8, 2008 and is headquartered inPennington, NJ.

Sector

Health Services

Industry

Medical and Nursing Services

Employees

38

CEO

Daniel J. O'Connor

Exchange

NASDAQ

Website

http://www.oncosec.com

$NoneM

Total Revenue

38

Employees

$25.61M

Market Capitalization

-0.68

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
DaVita, Inc. DVA 11671.20 11487.00 5.07 12.95 7.85
Chemed Corp. CHE 7945.12 1992.00 10.85 33.41 11.60
Guardant Health, Inc. GH 7770.15 245.00 10.52 -100.66 -31.53
Amedisys, Inc. AMED 6736.62 1980.00 9.73 53.02 6.43
LHC Group, Inc. LHCG 5492.58 2091.00 3.91 55.89 4.73
1Life Healthcare, Inc. ONEM 4827.06 292.00 10.38 -60.81 -27.31
NeoGenomics, Inc. NEO 3591.28 419.00 7.37 847.00 0.82
Natera, Inc. NTRA 3509.84 330.00 14.61 -28.28 -38.27
SmileDirectClub, Inc. SDC 3118.50 769.00 9.88 -25.31 -16.02
Invitae Corp. NVTA 3045.12 241.00 12.15 -9.97 -125.90
The Ensign Group, Inc. ENSG 2376.08 2155.00 3.37 19.20 5.76
Acadia Healthcare Co., Inc. ACHC 2250.16 3130.00 0.92 19.98 3.61
MEDNAX, Inc. MD 1449.18 3508.00 1.00 -1.14 -36.30
Addus HomeCare Corp. ADUS 1289.96 598.00 3.05 62.68 3.33
U.S. Physical Therapy, Inc. USPH 1051.18 478.00 4.31 35.78 6.03
RadNet, Inc. RDNT 791.50 1164.00 6.46 395.75 0.18
Castle Biosciences, Inc. CSTL 653.99 61.00 7.59 641.17 9.75
The Pennant Group, Inc. PNTG 640.64 352.00 8.38 152.53 1.19
Option Care Health, Inc. OPCH 627.36 2539.00 2.65 -6.41 -3.63
Hanger, Inc. HNGR 612.18 1095.00 -38.36 32.88 1.71
Tivity Health, Inc. TVTY 540.00 1255.00 70.31 -1.09 -38.98
Catasys, Inc. CATS 440.13 41.00 -16.08 -14.15 -74.67
Fulgent Genetics, Inc. FLGT 324.20 35.00 4.32 -1621.00 -1.31
OptiNose, Inc. OPTN 277.35 37.00 8.38 -2.52 -295.66
American Renal Associates Holdings, Inc. ARA 205.12 824.00 -2.54 -11.45 -2.19
Aptinyx, Inc. APTX 179.64 4.00 1.86 -3.22 -810.48
Exagen, Inc. XGN 165.75 41.00 3.19 -5.18 -76.21
CRH Medical Corp. CRHM 163.52 117.00 2.15 112.00 1.52
Pro-Dex, Inc. PDEX 71.72 31.00 3.98 16.30 14.50
Guardion Health Sciences, Inc. GHSI 35.70 1.00 2.62 -1.56 -824.43
Cardiff Oncology, Inc. CRDF 30.17 0.00 12.31 -1.97 -883.77
OncoSec Medical, Inc. ONCS 25.61 None 2.10 -0.68 None
Biocept, Inc. BIOC 25.08 6.00 3.88 -0.92 -463.58
Capital Senior Living Corp. CSU 21.60 439.00 -0.69 -0.31 -16.00
American Shared Hospital Services AMS 12.66 20.00 0.46 52.75 1.28
IMAC Holdings, Inc. IMAC 10.98 16.00 1.26 -1.63 -42.30
TrovaGene, Inc. TROV 8.04 0.00 2.03 -0.48 -883.77

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

OncoSec Medical Inc.

4d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

OncoSec Medical (NASDAQ:ONCS) Shares Pass Above 200 Day Moving Average of $1.83

8d ago, source: modernreaders.com

OncoSec Medical Inc (NASDAQ:ONCS) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day ...

10-Q: ONCOSEC MEDICAL INC

In Depth ago, source: MarketWatch

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. Unless the context ...

OncoSec to Present at Virtual Summer Investor Summit

5d ago, source: Bloomberg

Before it's here, it's on the Bloomberg Terminal.

OncoSec Expands KEYNOTE-890 Trial into First-Line Metastatic Triple Negative Breast Cancer (mTNBC) with TAVO™ and KEYTRUDA® Plus Chemotherapy

26d ago, source: YAHOO!

- Tumor Shrinkage and Related Clinical Responses Observed in KEYNOTE-890 in Heavily Pretreated mTNBC Patients Supports Moving to a First-Line Treatment PENNINGTON, N.J. and SAN DIEGO, June 9, 2020 ...

OncoSec Presents Two Late-Breaking Abstracts on TAVO-PLUS at the American Association for Cancer Research (AACR) Virtual Annual Meeting II

13d ago, source: The Trentonian

About OncoSec Medical Incorporated OncoSec Medical Incorporated is a late-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's ...

10-Q: ONCOSEC MEDICAL INC

21d ago, source: MarketWatch

Unless the context indicates otherwise, all references to "OncoSec," "our company ... Holdings Limited ("CGP"), and Sirtex Medical US Holdings, Inc. ("Sirtex") financing transaction.



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.